HUMAN LUNG NEUTRAL METALLOENDOPEPTIDASE
人肺中性金属内肽酶
基本信息
- 批准号:3082727
- 负责人:
- 金额:$ 8.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-09-01 至 1994-08-31
- 项目状态:已结题
- 来源:
- 关键词:asthma complementary DNA endonuclease endopeptidases enzyme mechanism genetic transcription genetic translation high performance liquid chromatography human tissue immunoprecipitation laboratory rabbit lung disorder metalloenzyme molecular cloning nucleic acid hybridization nucleic acid probes protein biosynthesis protein degradation protein sequence protein structure function respiratory airflow disorder respiratory epithelium respiratory function tissue /cell culture
项目摘要
The applicant proposes to learn and apply the tools of cell biology and
molecular biology to a research area relevant to human lung disease.
A number of regulatory peptides with potent physiologic pro-inflammatory,
and growth promoting effects have been localized to the lung. A neutral
metalloendopeptidase (NEP) appears to play a key role in degrading many of
these peptides. The modulation of NEP will thus likely impact on the extent
of the peptides' effects. NEP has recently been localized to the lung and
evidence suggests that it is relevant to reactive airways disease.
The long term objective is to understand the role and regulation of NEP in
normal and diseased human airways. The specific aims of this proposal are
to: 1) Fully characterize the purified human lung NEP from a structural,
functional, and immunological standpoint. 2) Clone the gene from human cDNA
and genomic libraries. The deduced amino acid sequence will likely provide
additional information on the structure and function of the enzyme. This
work will also provide the tools necessary to examine regulation of NEP at
the transcriptional level. 3) Comprehensively assess modulation of
epithelial cell NEP from the transcriptional to post-translational level.
This work will consist of three major thrusts. The first will be a
systematic screening of potential modulating factors in epithelial cell
cultures. The second will be an examination of the effects of specific
modulating factors on synthesis and degradation of NEP utilizing metabolic
labelling and immunoprecipitation. The final thrust will be an
incorporation of the DNA probe into the studies for an assessment of
transcriptional regulation.
The environment at the University of Utah is ideal for developing the
investigative career of the applicant. Within the Pulmonary Division, or
closely aligned, are a capable group of investigators with a wide range of
interests from basic biochemistry, immunology, and molecular biology to
physics and clinical physiology. Pulmonary research conferences, seminars,
and journal clubs foster open communication in the Division. The sponsors
of this proposal, Dr. John Hoidal and Dr. Ray White, are highly productive
investigators with an excellent track record in developing young people.
The University of Utah is particularly strong in the area of molecular
biology and this proposal taps that potential.
Through the application of the techniques of molecular biology to this
proposal, the interaction with other basic science faculty and trainees
with similar interests, and graduate course work, the applicant will gain a
solid foundation in molecular biology.
申请人建议学习和应用细胞生物学的工具和
分子生物学到与人类肺部疾病相关的研究领域。
许多具有强效生理促炎作用的调节肽,
生长促进作用已定位于肺部。中立的
金属内肽酶 (NEP) 似乎在降解许多
这些肽。因此,NEP 的调整可能会影响程度
肽的作用。 NEP 最近已定位于肺部
有证据表明它与反应性气道疾病有关。
长期目标是了解 NEP 在
正常和患病的人类呼吸道。该提案的具体目标是
1) 从结构、
功能和免疫学的观点。 2) 从人类cDNA中克隆基因
和基因组文库。推导的氨基酸序列可能会提供
有关酶结构和功能的其他信息。这
工作还将提供必要的工具来审查 NEP 的监管
转录水平。 3)综合评估调制
上皮细胞NEP从转录到翻译后水平。
这项工作将包括三个主要重点。第一个将是
系统筛选上皮细胞中潜在的调节因子
文化。第二步是检查具体措施的效果
利用代谢调节 NEP 合成和降解的因素
标记和免疫沉淀。最后的推动力将是
将 DNA 探针纳入研究中以评估
转录调控。
犹他大学的环境非常适合发展
申请人的调查生涯。在肺科内,或
密切配合,是一个有能力的研究人员小组,具有广泛的
基础生物化学、免疫学和分子生物学的兴趣
物理学和临床生理学。肺研究会议、研讨会、
和期刊俱乐部促进该部门的开放式沟通。赞助商
John Hoidal 博士和 Ray White 博士对这项提案的提出非常有成效
调查员在培养年轻人方面有着出色的记录。
犹他大学在分子领域尤其强大
生物学和这项提案挖掘了这种潜力。
通过分子生物学技术的应用
提案、与其他基础科学教师和学员的互动
具有相似的兴趣和研究生课程,申请人将获得
扎实的分子生物学基础。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1 beta and tumor necrosis factor-alpha.
肺上皮细胞尿激酶型纤溶酶原激活剂。
- DOI:
- 发表时间:1992
- 期刊:
- 影响因子:0
- 作者:Marshall,BC;Xu,QP;Rao,NV;Brown,BR;Hoidal,JR
- 通讯作者:Hoidal,JR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUCE C MARSHALL其他文献
BRUCE C MARSHALL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUCE C MARSHALL', 18)}}的其他基金
OPEN LABEL PILOT OF SAFETY, PHARMACOKINETICS, & EFFICACY OF MIKASOME
安全性、药代动力学、
- 批准号:
6304893 - 财政年份:1999
- 资助金额:
$ 8.26万 - 项目类别:
OPEN LABEL PILOT OF SAFETY, PHARMACOKINETICS, & EFFICACY OF MIKASOME
安全性、药代动力学、
- 批准号:
6419490 - 财政年份:1999
- 资助金额:
$ 8.26万 - 项目类别:
AEROSOLIZED TYLOXAPOL IN THE AIRWAYS DISEASE OF CYSTIC FIBROSIS
雾化泰洛沙泊治疗气道囊性纤维化疾病
- 批准号:
6304927 - 财政年份:1999
- 资助金额:
$ 8.26万 - 项目类别:
STUDY OF NONTUBERCULOUS MYCOBACTERIA IN PATIENTS WITH CYSTIC FIBROSIS
囊性纤维化患者非结核分枝杆菌的研究
- 批准号:
6114825 - 财政年份:1998
- 资助金额:
$ 8.26万 - 项目类别:
AEROSOLIZED TYLOXAPOL IN THE AIRWAYS DISEASE OF CYSTIC FIBROSIS
雾化泰洛沙泊治疗气道囊性纤维化疾病
- 批准号:
6114854 - 财政年份:1998
- 资助金额:
$ 8.26万 - 项目类别:
AEROSOLIZED TYLOXAPOL IN THE AIRWAYS DISEASE OF CYSTIC FIBROSIS
雾化泰洛沙泊治疗气道囊性纤维化疾病
- 批准号:
6218447 - 财政年份:1998
- 资助金额:
$ 8.26万 - 项目类别:
PHASE III TRIAL OF TOBRAMYCIN IN TREATMENT OF P AERUGINOSA IN CYSTIC FIBROSIS
妥布霉素治疗铜绿假单胞菌囊性纤维化的 III 期试验
- 批准号:
6114838 - 财政年份:1998
- 资助金额:
$ 8.26万 - 项目类别:
STUDY OF NONTUBERCULOUS MYCOBACTERIA IN PATIENTS WITH CYSTIC FIBROSIS
囊性纤维化患者非结核分枝杆菌的研究
- 批准号:
6218418 - 财政年份:1998
- 资助金额:
$ 8.26万 - 项目类别:
相似海外基金
Development of a highly integrated circuit using DNA and a demonstration test of the parallel computation using a complementary DNA as an operator
使用DNA的高度集成电路的开发以及使用互补DNA作为算子的并行计算的演示测试
- 批准号:
17K06395 - 财政年份:2017
- 资助金额:
$ 8.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Quantitative analysis in neurotrophic factor genes of spinal cord with complementary DNA microarray
互补DNA微阵列定量分析脊髓神经营养因子基因
- 批准号:
18390411 - 财政年份:2006
- 资助金额:
$ 8.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of gene expression following maxillofacial inflammation in rat using complementary DNA microarray
使用互补 DNA 微阵列分析大鼠颌面部炎症后的基因表达
- 批准号:
15390628 - 财政年份:2003
- 资助金额:
$ 8.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Complementary DNA cloning and characterization of rat spergen-3,a spermatogenic cell-specific gene-3,expressed in mammalian spermatogenic cells
大鼠 spergen-3(生精细胞特异性基因 3,在哺乳动物生精细胞中表达)的互补 DNA 克隆和表征
- 批准号:
15570179 - 财政年份:2003
- 资助金额:
$ 8.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Microbial Genome Sequencing: Gene Discovery and Mapping Tools for Ichthyophthirius: A Complementary DNA Resource
微生物基因组测序:鱼霉属基因发现和作图工具:补充 DNA 资源
- 批准号:
0333246 - 财政年份:2003
- 资助金额:
$ 8.26万 - 项目类别:
Continuing Grant
GENE EXPRESSION ANALYSIS OF THE SPINAL CORD UNDER CHRONIC MECHANICAL COMPRESSION USING IN-HOUSE COMPLEMENTARY DNA MICROARRAY
使用内部互补 DNA 微阵列对慢性机械压迫下的脊髓进行基因表达分析
- 批准号:
15591563 - 财政年份:2003
- 资助金额:
$ 8.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of antisense vascular endothelial growth factor complementary DNA on the growth of human glioma cells.
反义血管内皮生长因子互补DNA对人胶质瘤细胞生长的影响。
- 批准号:
07671538 - 财政年份:1995
- 资助金额:
$ 8.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)